Revium Rx (RVRC) Accounts Payables (2024 - 2025)

Revium Rx's (RVRC) quarterly Accounts Payables came in at $163000.0 in Q4 2025, up 14.79% year-on-year from $142000.0 in Q4 2024, and up 14.79% quarter-over-quarter from $142000.0 in Q4 2024.

Revium Rx (RVRC) Accounts Payables (2024 - 2025) Analysis & Trends

Revium Rx has disclosed Accounts Payables across 2 years of filings, most recently posting $163000.0 for Q4 2025.

  • Accounts Payables for Q4 2025 came in at $163000.0, up 14.79% year-over-year; the trailing twelve-month figure through Dec 2025 was $163000.0 (up 14.79% YoY), and the FY2025 annual result was $163000.0, up 14.79% from the prior year.
  • Accounts Payables came in at $163000.0 for Q4 2025 at Revium Rx, up from $142000.0 in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $163000.0 in Q4 2025 to a low of $142000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Veeva Systems 24.83 Bn 17.52 Bn 662.02 Mn 40.66 Mn
2 BrightSpring Health Services 13.57 Bn 12.69 Bn 482.22 Mn 1.09 Bn
3 Healthequity 7.20 Bn 6.93 Bn 256.31 Mn 14.22 Mn
4 Hinge Health 5.42 Bn 5.11 Bn 154.23 Mn 69.48 Mn
5 10x Genomics 4.46 Bn 3.92 Bn 106.18 Mn 17.43 Mn
6 Doximity 3.81 Bn 3.06 Bn 125.97 Mn 4.01 Mn
7 Waystar Holding 3.52 Bn 3.36 Bn 268.04 Mn 58.80 Mn
8 Privia Health 2.94 Bn 2.57 Bn 595.71 Mn 80.56 Mn
9 Omnicell 1.76 Bn 1.59 Bn 140.36 Mn 58.34 Mn
10 Revium Rx - - - 163,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 163,000.00
Dec 31, 2024 142,000.00